Streetbeat News

Price Targets

CTM

EF Hutton analyst Edward Reilly has maintained a Buy rating on Castellum (AMEX:CTM) but has reduced the price target from $1.4 to $1.15.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:45 pm

GMDA

HC Wainwright & Co. analyst Vernon Bernardino has maintained a Buy rating on Gamida Cell (NASDAQ:GMDA) but has reduced the price target from $11 to $5. This adjustment reflects a change in valuation but still suggests confidence in the company's potential.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:45 pm

GOEV

HC Wainwright & Co. analyst Amit Dayal has maintained a Buy rating on Canoo (NASDAQ:GOEV) but has reduced the price target from $10 to $3. This adjustment reflects a more conservative valuation of the company's prospects.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:42 pm

GOOG

GOOGL

NFLX

Piper Sandler's biannual survey shows that American teens spend 57.8% of their daily video viewing time on YouTube and Netflix, with YouTube leading at 29.1% and Netflix at 28.7%. YouTube's market share increased by 1% since spring, while Netflix's share dropped by 2.2%. Both platforms have raised subscription prices, which may have influenced these changes. The survey also noted a decline in time spent on cable TV, HBO Max, and Hulu, but an increase for Amazon Prime Video and Disney+.

Portfolio Pulse from Rounak Jain

November 15, 2023 | 12:42 pm

CASI

HC Wainwright & Co. analyst Sean Lee has reaffirmed a Buy rating on CASI Pharmaceuticals (NASDAQ:CASI) and increased the price target from $10 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:40 pm

ALLO

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Allogene Therapeutics (NASDAQ:ALLO) but reduced the price target from $23 to $12.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:38 pm

SLE

HC Wainwright & Co. analyst Scott Buck has reaffirmed a Buy rating on Super League Enterprise (NASDAQ:SLE) and increased the price target from $2 to $5.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:37 pm

INTZ

HC Wainwright & Co. analyst Scott Buck has maintained a Neutral rating on Intrusion (NASDAQ:INTZ) but has lowered the price target from $1 to $0.5.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:28 pm

ONON

Telsey Advisory Group analyst Joseph Feldman has maintained an Outperform rating on On Holding (NYSE:ONON) but reduced the price target from $40 to $37.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:21 pm

YMAB

HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Y-mAbs Therapeutics (NASDAQ:YMAB) and maintained an $11 price target for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

November 15, 2023 | 12:21 pm